Cellular & Molecular Mechanisms of Repair

Growth Factor Signaling Cascades in Wound Repair

Growth factors are specialized polypeptide signaling molecules that bind to specific transmembrane receptors (primarily receptor tyrosine kinases) on target cell membranes. They direct cell migration (chemotaxis), cell division (mitogenesis), differentiation, and extracellular matrix (ECM) production via autocrine, paracrine, and juxtacrine signaling pathways.

Key Growth Factors & Biological Functions

1. Platelet-Derived Growth Factor (PDGF):
   • Primary Sources: Platelet alpha-granules, activated macrophages, endothelial cells, smooth muscle cells.
   • Target Cells: Fibroblasts, smooth muscle cells, neutrophils, macrophages.
   • Functions: Potent chemoattractant for inflammatory cells and fibroblasts; directly stimulates fibroblast proliferation and type I collagen synthesis; promotes wound contraction.
   • Clinical Relevance: Recombinant human PDGF-BB (Becaplermin / Regranex) is an FDA-approved topical growth factor indicated for lower extremity neuropathic diabetic foot ulcers extending into subcutaneous tissue.
2. Transforming Growth Factor-Beta (TGF-beta):
   • Primary Sources: Platelets, macrophages, T-lymphocytes, fibroblasts.
   • Functions: Master driver of ECM deposition; stimulates fibroblasts to produce collagen types I and III, fibronectin, and proteoglycans; downregulates MMP expression while upregulating TIMP synthesis.
   • Pathology: Dysregulated, excessive TGF-beta signaling is heavily implicated in excessive fibrosis, hypertrophic scar formation, and keloids.
3. Vascular Endothelial Growth Factor (VEGF):
   • Primary Sources: Macrophages, keratinocytes, fibroblasts (stimulated by local hypoxia via HIF-1alpha).
   • Target Cells: Endothelial cells.
   • Functions: Primary driver of angiogenesis; induces endothelial cell migration, proliferation, and microvascular permeability.
4. Epidermal Growth Factor (EGF) & Transforming Growth Factor-Alpha (TGF-alpha):
   • Primary Sources: Platelets, macrophages, submandibular glands.
   • Target Cells: Keratinocytes, epithelial cells.
   • Functions: Accelerates re-epithelialization by stimulating keratinocyte proliferation and migration across the wound bed.
5. Fibroblast Growth Factors (FGF-1 / Acidic FGF, FGF-2 / Basic FGF):
   • Primary Sources: Macrophages, endothelial cells, chondrocytes.
   • Functions: Stimulates fibroblast proliferation, granulation tissue formation, and endothelial cell migration.

---

Matrix Metalloproteinases (MMPs) vs. TIMPs Equilibrium

Matrix Metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases secreted by neutrophils, macrophages, fibroblasts, keratinocytes, and endothelial cells. In physiological tissue repair, MMPs function to degrade damaged ECM components, facilitate cell migration through dense matrix barriers, and participate in scar remodeling.

Classification of Major MMPs

• Interstitial Collagenases (MMP-1, MMP-8, MMP-13): Cleave native, triple-helical collagen types I, II, and III. MMP-1 is produced primarily by keratinocytes and fibroblasts; MMP-8 is released by neutrophils.
• Gelatinases (MMP-2, MMP-9): Degrade denatured collagen (gelatin), type IV basement membrane collagen, fibronectin, and elastin. MMP-9 is heavily released by PMNs during inflammation.
• Stromelysins (MMP-3, MMP-10): Cleave proteoglycans, laminin, fibronectin, and activate pro-MMP precursor zymogens.

Tissue Inhibitors of Metalloproteinases (TIMPs)

To prevent uncontrolled tissue destruction, active MMPs are strictly regulated by endogenously produced inhibitors known as Tissue Inhibitors of Metalloproteinases (TIMPs 1–4). TIMPs bind to active MMP catalytic sites in a 1:1 stoichiometric ratio, neutralizing their enzymatic activity.

ACUTE WOUND (Balanced Environment):
[Low/Transient MMPs] : [High/Adequate TIMPs] ──> Controlled ECM Turnover & Healing

CHRONIC WOUND (Proteolytic Imbalance):
[MMPs Elevated 10-100x] : [Low/Suppressed TIMPs] ──> ECM Destruction & Growth Factor Degradation

Proteolytic Imbalance in Chronic Wounds

In healthy acute wounds, MMP levels rise briefly during early inflammation and proliferation to clear damaged tissue, rapidly normalizing as TIMP levels rise.

In chronic non-healing wounds (e.g., chronic venous leg ulcers, pressure injuries, diabetic foot ulcers), this homeostatic balance collapses:

• MMP levels are elevated 10 to 100 times higher than in acute wounds.
• TIMP levels are markedly depressed.
• Result: The overwhelming excess of active proteases (MMP-2, MMP-8, MMP-9, and neutrophil elastase) non-selectively degrades newly deposited collagen, cleaves fibronectin migration tracks, destroys endogenous growth factors (PDGF, VEGF), and inactivates growth factor cell surface receptors.

---

Extracellular Matrix (ECM) Components & Dynamics

The Extracellular Matrix (ECM) is a dynamic 3D structural and functional network that provides physical scaffolding for cells, stores growth factors, and transmits mechanical and biochemical signals that regulate cell behavior.

Fibronectin & Hyaluronic Acid in Early Repair

• Fibronectin: Acts as a vital bridging protein. Plasma fibronectin incorporates into the provisional fibrin clot, while tissue fibronectin is secreted by fibroblasts. Integrin cell receptors (such as alpha-5-beta-1) bind to fibronectin's RGD (Arg-Gly-Asp) amino acid sequence, enabling keratinocytes and fibroblasts to march across the wound bed.
• Hyaluronic Acid (Hyaluronan): A massive, non-sulfated glycosaminoglycan with immense osmotic water-binding capacity. In early wound healing, hyaluronan expands the interstitial space, forming a porous, highly hydrated matrix that facilitates cell motility, nutrient diffusion, and early tissue swelling.

---

Molecular Pathology of Chronic Non-Healing Wounds

When acute wounds fail to progress through the orderly phases of repair, they become trapped in a self-perpetuating chronic inflammatory loop.

Features of the Chronic Wound Microenvironment

1. Persistent Inflammatory Infiltrate: Continuous influx of hyperactive neutrophils releasing high levels of pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6).
2. Elevated Protease & ROS Activity: Massive excess of MMP-8, MMP-9, elastase, and reactive oxygen species that destroy healthy matrix components faster than fibroblasts can synthesize them.
3. Growth Factor Inactivation: Endogenous growth factors (PDGF, VEGF, TGF-beta) are degraded within hours of secretion by excessive proteases.
4. Phenotypic Cellular Senescence: Chronic wound fibroblasts and endothelial cells become senescent. Although structurally present, these cells exhibit altered morphology, reduced proliferative capacity, diminished responsiveness to growth factor stimulation, and decreased collagen synthesis capability.

Clinical Takeaway: Advanced wound therapies—such as collagen dressings, oxidized regenerated cellulose (ORC)/collagen matrices, and bioengineered skin equivalents—work by binding and neutralizing excess MMPs, sacrificing themselves to protect endogenous growth factors and restore molecular equilibrium.